Breaking News
InnoCan startet in eine neue Ära – FDA Zulassung!
Anzeige
CYNGN ISIN: US23257B1070 Forum: Aktien User: Ni1976
0,121 USD
±0,00 %±0,000
23. Apr, 11:44:08 Uhr,
UTP Consolidated
Kommentare 63
Henderson,
23. Feb 3:00 Uhr
0
🥷🏿
M
Müllerknüller,
25. Jan 16:36 Uhr
0
Ja
Nixblicker,
25. Jan 14:03 Uhr
0
Habt ihr die Aktie über die nasdaq gekauft?
A
Ahnungsloser1,
25. Jan 13:18 Uhr
0
https://investors.cyngn.com/news/cyngn-s-next-gen-drivemod-kit-will-harness-nvidia-ai-computers/76e1b17f-ba20-4185-b2c3-b864db2dae1f/
Robo1976,
25. Jan 13:16 Uhr
1
Cyngn's Next-Gen DriveMod Kit Will Harness Nvidia AI Computers
Robo1976,
24. Jan 6:52 Uhr
0
⏰
?
?????,
23. Jan 13:50 Uhr
0
Vielleicht bald ☺️🌻
shervi,
18.01.2024 12:37 Uhr
0
Ist jemand hier noch drin ?
shervi,
09.01.2024 14:49 Uhr
0
Cyngn Secures its 18th U.S. Patent in Adaptive Traffic Rule-Based Decision Making for Autonomous Driving
Jan 09, 2024 7:05 AM
Since August 2023, Cyngn has been granted eight additional patents, bringing the total U.S. patents granted to 18.
MENLO PARK, Calif., Jan. 9, 2024 /PRNewswire/ - Cyngn Inc. (the "Company" or "Cyngn") (Nasdaq: CYN), a developer of Al-powered autonomous driving solutions for industrial applications, today announced the issuance of a new patent, US-11,837,090-B2, for the Company's autonomous vehicle (AV) and driving solutions. This new patent protects Cyngn's novel adaptive traffic rule-based decision making for autonomous driving that aims to optimize driving decisions in the presence of multiple rules or constraints imposed on an autonomous vehicle by its environment.
囗
"As our business continues its upward trajectory, the significance of our patents becomes increasingly evident," said Cyngn's Chairman and Chief Executive Officer, Lior Tal. "These patents are not just legal safeguards; they are the cornerstone of our growth strategy, ensuring that our innovative ideas remain exclusively ours in a competitive market. In essence, they are the protective armor that fortifies our position in the industry, allowing us to confidently forge ahead in our journey of expansion and success."
Cyngn provides its customers a seamless way to adopt self-driving technology into their operations without high upfront costs or the need to completely replace existing vehicle investments.
Cyngn's patent family is comprised of the following granted patents:
d
dippchaser,
26.12.2023 21:45 Uhr
0
Irgendwelche Prognosen für 2024? 🚀
Robo1976,
07.12.2023 17:38 Uhr
0
😌
Kasi77,
07.12.2023 17:26 Uhr
0
👀
Robo1976,
07.12.2023 13:18 Uhr
0
Cyngn Granted 17th U.S. Patent for its AI-Powered Autonomous Vehicle Technologies
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | TESLA MOTORS Hauptdiskussion | +0,74 % | |
2 | HELLOFRESH SE INH O.N. Hauptdiskussion | +2,61 % | |
3 | MEYER BURGER Hauptdiskussion | ±0,00 % | |
4 | Jaguar Health für Investierte und Interessierte | +13,83 % | |
5 | About You Holdings | +5,82 % | |
6 | Vivoryon Therapeutics | +20,13 % | |
7 | Nantkwest / Immunitybio -> IBRX | +27,42 % | |
8 | SUPER MICRO Hauptdiskussion | +1,50 % | |
9 | Trading- und Aktien-Chat | ||
10 | RHEINMETALL Hauptdiskussion | +1,02 % | Alle Diskussionen |
Anzeige
Aktien
|
Thema | ||
---|---|---|---|
1 | TESLA MOTORS Hauptdiskussion | +0,72 % | |
2 | HELLOFRESH SE INH O.N. Hauptdiskussion | +2,61 % | |
3 | MEYER BURGER Hauptdiskussion | ±0,00 % | |
4 | About You Holdings | +5,82 % | |
5 | Jaguar Health für Investierte und Interessierte | +13,83 % | |
6 | Vivoryon Therapeutics | +20,13 % | |
7 | Nantkwest / Immunitybio -> IBRX | +27,36 % | |
8 | SUPER MICRO Hauptdiskussion | +1,50 % | |
9 | RHEINMETALL Hauptdiskussion | +1,02 % | |
10 | AMERICAN LITHIUM Hauptdiskussion | -5,92 % | Alle Diskussionen |